Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI

NCT ID: NCT01696838

Last Updated: 2016-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of Crohn's disease. Meanwhile, the investigators aim to evaluate the efficacy by functional magnetic resonance imaging.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine whether acupuncture or moxibustion therapies are effective in the treatment of Crohn's disease. meanwhile, the investigators aim to evaluate the efficacy by functional magnetic resonance imaging.

Through treating quiescent Crohn's disease by electroacupuncture or moxibustion therapies for 12 weeks, Compare the different brain activation by the different therapies and observe the correlation between brain activation and efficacy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn's Disease CAM

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EA group

Electroacupuncture group

Group Type EXPERIMENTAL

electroacupuncture

Intervention Type OTHER

Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.

moxibustion

Intervention Type OTHER

patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.

MOX group

Herbs-partitioned moxibustion group

Group Type EXPERIMENTAL

electroacupuncture

Intervention Type OTHER

Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.

moxibustion

Intervention Type OTHER

patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electroacupuncture

Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.

Intervention Type OTHER

moxibustion

patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

acupuncture herbs-partitioned moxibustion

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-50 years;
* right-handed;
* clinical remission (Crohn's Disease Activity Index \[CDAI\]≤150) for at least 6 months prior to the study;
* C-reactive protein(CRP)\<10 mg/l;
* erythrocyte sedimentation rate (ESR) \<20 mm/h
* signing awritten informed consent form.

Exclusion Criteria

* use of corticosteroids and psychotropic medications in the previous 30 days;
* current or prior history of neurological or psychiatric disease based
* on physicians' examination and questionnaires;
* current or prior history of neurosurgery, head injury, cerebrovascular
* insult, or brain trauma involving loss of consciousness;
* learning disability;
* claustrophobia;
* presence of metallic implants in the body;
* being pregnant or during lactation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Institute of Acupuncture, Moxibustion and Meridian

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wu Huangan, PhD

Role: STUDY_CHAIR

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Institute of Acupuncture-Moxibustion and Merdian

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHACU-201201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Helmsley 3.0: Abbreviated MRE
NCT06533228 RECRUITING
Response Assessment in SB CD
NCT03646708 RECRUITING